Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Shirley, Lazar"'
Autor:
Inbar Cohen-Gihon, Galia Zaide, Sharon Amit, Iris Zohar, Orna Schwartz, Yasmin Maor, Ofir Israeli, Gal Bilinsky, Ma’ayan Israeli, Shirley Lazar, David Gur, Moshe Aftalion, Anat Zvi, Adi Beth-Din, Erez Bar-Haim, Uri Elia, Ofer Cohen, Emanuelle Mamroud, Theodor Chitlaru
Publikováno v:
BMC Genomic Data, Vol 25, Iss 1, Pp 1-4 (2024)
Abstract Objective Burkholderia pseudomallei, the etiological cause of melioidosis, is a soil saprophyte endemic in South-East Asia, where it constitutes a public health concern of high-priority. Melioidosis cases are sporadically identified in nonen
Externí odkaz:
https://doaj.org/article/ad0550d172cd45f89daa2d0401a2cde8
Autor:
Inbar Cohen-Gihon, Ofir Israeli, Gal Bilinsky, Barak Vasker, Shirley Lazar, Adi Beth-Din, Anat Zvi, Nesrin Ghanem-Zoubi, Yafit Atiya-Nasagi
Publikováno v:
New Microbes and New Infections, Vol 59, Iss , Pp 101242- (2024)
The diagnosis of Q fever is challenging due to nonspecific symptoms and negative standard blood culture results. Serological testing through immunofluorescence assay (IFA) is the most commonly used method for diagnosing this disease. Polymerase chain
Externí odkaz:
https://doaj.org/article/a536fb6474ed4e2abc711c7b46dbf514
Autor:
Noam Cohen, Irit Simon, Ophir Hazan, Arnon Tal, Hanan Tzadok, Lilach Levin, Meni Girshengorn, Lilach Cherry Mimran, Niva Natan, Tzadok Baruhi, Alon Ben David, Osnat Rosen, Shlomo Shmaya, Sarah Borni, Noa Cohen, Edith Lupu, Adi Kedmi, Orian Zilberman, Avital Jayson, Arik Monash, Eyal Dor, Eran Diamant, Michael Goldvaser, Inbar Cohen-Gihon, Ofir Israeli, Shirley Lazar, Ohad Shifman, Adi Beth-Din, Anat Zvi, Ziv Oren, Arik Makovitzki, Elad Lerer, Avishai Mimran, Einat Toister, Ran Zichel, Yaakov Adar, Eyal Epstein
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The COVID-19 pandemic has led to high global demand for vaccines to safeguard public health. To that end, our institute has developed a recombinant viral vector vaccine utilizing a modified vesicular stomatitis virus (VSV) construct, wherein the G pr
Externí odkaz:
https://doaj.org/article/decca5fe62ee475690287d8e70308a6f
Autor:
Ronit Rosenfeld, Ron Alcalay, Anat Zvi, Alon Ben-David, Tal Noy-Porat, Theodor Chitlaru, Eyal Epstein, Ofir Israeli, Shirley Lazar, Noa Caspi, Ada Barnea, Eyal Dor, Inbar Chomsky, Shani Pitel, Efi Makdasi, Ran Zichel, Ohad Mazor
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Hyper-immune antisera from large mammals, in particular horses, are routinely used for life-saving anti-intoxication intervention. While highly efficient, the use of these immunotherapeutics is complicated by possible recipient reactogenicity and lim
Externí odkaz:
https://doaj.org/article/30b19251d1ca439abe77d48d5514e1c8
Autor:
Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, Efi Makdasi, Yinon Levy, Ron Alcalay, Reut Falach, Moshe Aftalion, Eyal Epstein, David Gur, Theodor Chitlaru, Einat B. Vitner, Sharon Melamed, Boaz Politi, Ayelet Zauberman, Shirley Lazar, Adi Beth-Din, Yentl Evgy, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Ohad Mazor
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Here, using the K18-hACE2 transgenic mice model, the authors report the in vivo efficacy of a fully human neutralizing antibody against SARS-CoV-2 and show that when administered before or up to 3 days post infection, treated mice do not exhibit dise
Externí odkaz:
https://doaj.org/article/46809b3d714542f1b041f07ea3d49be0
Autor:
Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Ohad Shifman, Hagit Achdout, Einat B. Vitner, Ofir Israeli, Elad Milrot, Dana Stein, Inbar Cohen-Gihon, Shlomi Lazar, Hila Gutman, Itai Glinert, Lilach Cherry, Yaron Vagima, Shirley Lazar, Shay Weiss, Amir Ben-Shmuel, Roy Avraham, Reut Puni, Edith Lupu, Elad Bar-David, Assa Sittner, Noam Erez, Ran Zichel, Emanuelle Mamroud, Ohad Mazor, Haim Levy, Orly Laskar, Shmuel Yitzhaki, Shmuel C. Shapira, Anat Zvi, Adi Beth-Din, Nir Paran, Tomer Israely
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Here, the authors generate a replication-competent VSV based vaccine expressing SARS-CoV-2 spike protein and show protection in the hamster model with one dose. Analysis of the antibody response in mice shows induction of neutralizing antibodies and
Externí odkaz:
https://doaj.org/article/c9dbfd8736364f25b7884f0d5634e9e1
Autor:
Ofir Israeli, Adi Beth-Din, Nir Paran, Dana Stein, Shirley Lazar, Shay Weiss, Elad Milrot, Yafit Atiya-Nasagi, Shmuel Yitzhaki, Orly Laskar, Ofir Schuster
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss , Pp 352-354 (2020)
The genetic identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is based on viral RNA extraction prior to RT-qPCR assay. However, recent studies have supported the elimination of the extraction step. This study was performe
Externí odkaz:
https://doaj.org/article/f8220712ac3a43c9bbbc4aadd4ca32d8
Autor:
Shahar Rotem, Erez Bar-Haim, Uri Elia, Hila Cohen, Shirley Lazar, Ofer Cohen, Theodor Chitlaru, Yoav Gal
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1593 (2022)
The design of efficient vaccines for long-term protective immunity against pathogens represents an objective of utmost public health priority. In general, live attenuated vaccines are considered to be more effective than inactivated pathogens, yet po
Externí odkaz:
https://doaj.org/article/2f07bba166a547eaadbbd9b1689c206e
Autor:
Ofir Israeli, Yehoudit Guedj-Dana, Ohad Shifman, Shirley Lazar, Inbar Cohen-Gihon, Sharon Amit, Ronen Ben-Ami, Nir Paran, Ofir Schuster, Shay Weiss, Anat Zvi, Adi Beth-Din
Publikováno v:
Viruses, Vol 14, Iss 8, p 1817 (2022)
As of July 2022, more than 16,000 laboratory-confirmed monkeypox (MPX) cases have been reported worldwide. Until recently, MPX was a rare viral disease seldom detected outside Africa. MPX virus (MPXV) belongs to the Orthopoxvirus (OPV) genus and is a
Externí odkaz:
https://doaj.org/article/c3a566e604f94a058c8a68957522384e
Autor:
Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, Moshe Aftalion, Reut Falach, Shani Leviatan Ben-Arye, Shirley Lazar, Ayelet Zauberman, Eyal Epstein, Theodor Chitlaru, Shay Weiss, Hagit Achdout, Jonathan D. Edgeworth, Raghavendra Kikkeri, Hai Yu, Xi Chen, Shmuel Yitzhaki, Shmuel C. Shapira, Vered Padler-Karavani, Ohad Mazor, Ronit Rosenfeld
Publikováno v:
iScience, Vol 24, Iss 5, Pp 102479- (2021)
Summary: Neutralizing antibodies represent a valuable therapeutic approach to countermeasure the current COVID-19 pandemic. Emergence of SARS-CoV-2 variants emphasizes the notion that antibody treatments need to rely on highly neutralizing monoclonal
Externí odkaz:
https://doaj.org/article/5be2c18d8ba44814aa7c3af9cabd005d